Active	Status	Sponsor type	Region	Phase	Filter
7 Active 0 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Schneider, Stephen
NCT05624268: Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD	Recruiting	3	255	US	Psilocybin, COMP360	COMPASS Pathways	Treatment Resistant Depression	02/25	02/26
Voyage, NCT06741228: A Phase 3 Trial of MM120 for Generalized Anxiety Disorder	Recruiting	3	200	US	Placebo, MM120 (LSD D-Tartrate)	Mind Medicine, Inc.	Generalized Anxiety Disorder	05/26	11/26
NCT06941844: A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)	Recruiting	3	140	US	Placebo, MM120 (LSD D-Tartrate)	Mind Medicine, Inc.	Major Depressive Disorder	11/26	05/27
NCT06419582: BHV-7000 Acute Treatment of Bipolar Mania	Completed	2/3	274	US	BHV-7000, Placebo	Biohaven Therapeutics Ltd.	Bipolar Disorder	01/25	01/25
NCT05407064: A Dose-Finding Study of MM-120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms	Completed	2	198	US	MM-120 (LSD D-Tartrate), Placebo	Mind Medicine, Inc.	Anxiety Generalized	10/23	11/23
IMPACT-2, NCT06215261: An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD	Recruiting	2	60	Europe, US, RoW	Methylone	Transcend Therapeutics	Post Traumatic Stress Disorder	12/25	12/25
NCT06419608: Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression	Recruiting	2	300	US	BHV-7000, Placebo	Biohaven Therapeutics Ltd.	Major Depressive Disorder	05/25	07/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Schneider, Stephen
NCT05624268: Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD	Recruiting	3	255	US	Psilocybin, COMP360	COMPASS Pathways	Treatment Resistant Depression	02/25	02/26
Voyage, NCT06741228: A Phase 3 Trial of MM120 for Generalized Anxiety Disorder	Recruiting	3	200	US	Placebo, MM120 (LSD D-Tartrate)	Mind Medicine, Inc.	Generalized Anxiety Disorder	05/26	11/26
NCT06941844: A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)	Recruiting	3	140	US	Placebo, MM120 (LSD D-Tartrate)	Mind Medicine, Inc.	Major Depressive Disorder	11/26	05/27
NCT06419582: BHV-7000 Acute Treatment of Bipolar Mania	Completed	2/3	274	US	BHV-7000, Placebo	Biohaven Therapeutics Ltd.	Bipolar Disorder	01/25	01/25
NCT05407064: A Dose-Finding Study of MM-120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms	Completed	2	198	US	MM-120 (LSD D-Tartrate), Placebo	Mind Medicine, Inc.	Anxiety Generalized	10/23	11/23
IMPACT-2, NCT06215261: An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD	Recruiting	2	60	Europe, US, RoW	Methylone	Transcend Therapeutics	Post Traumatic Stress Disorder	12/25	12/25
NCT06419608: Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression	Recruiting	2	300	US	BHV-7000, Placebo	Biohaven Therapeutics Ltd.	Major Depressive Disorder	05/25	07/25